Completely Regressed Cutaneous Melanocytic Lesion: Was It Benign or Was It Malignant?

Seminars in Oncology

Volumn 36, Issue 5, 2009, Pages 375-379

  Berger, Adam C ^a   McClay, Edward F ^a   Toporcer, Mary ^a   Wolchok, Jedd D ^a   Morris, Gloria J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOPSY; CASE REPORT; DERMATOLOGY; HUMAN; LYMPHOCYTIC INFILTRATION; MALE; MELANOCYTE; MELANOCYTIC NEVUS; MELANOMA; METASTASIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REMISSION; SKIN EXAMINATION;

DISEASE PROGRESSION; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEVUS, HALO; NEVUS, PIGMENTED; PHYSICIAN-PATIENT RELATIONS; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 70349781796     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2009.07.010     Document Type: Article

References (20)

1. Giuliano A.E., Moseley H.S., and Morton D.L. Clinical aspects of unknown primary melanoma. Ann Surg 191 (1980) 98-104
2. Chang P., and Knapper W.H. Metastatic melanoma of unknown primary. Cancer 49 (1982) 1106-1111
3. Reintgen D.S., McCarty K.S., Woodard B., Cox E., and Seigler H.F. Metastatic malignant melanoma with an unknown primary. Surg Gynecol Obstet 156 (1983) 335-340
4. Bodurtha A.J. Spontaneous regression of malignant melanoma. In: Clark Jr. W.H., Goldman L.I., and Mastrangelo M.J. (Eds). Human malignant melanoma (1978), Grune & Stratton, Orlando, FL 277-342
5. Elder D.E., Elenitsas R., Murphy G.F., and Xu X. Benign pigmented lesions and melanoma. In: Elder D.E. (Ed). Lever's histopathology of the skin. 9th ed. (2005), Lippincott Williams & Wilkins, Philadelphia 447-449
6. Zabawski Jr. E.J., and Cockerell C.J. Halo nevus. Emedicine.medscape.com/article/1057446-overview
7. Schmoeckel C., Wildi G., and Schafer T. Spitz nevus versus malignant melanoma: Spitz nevi predominate on the thighs in patients younger than 40 years of age, melanomas on the trunk in patients forty years of age or older. J Am Acad Dermatol 56 (2007) 753-758
8. Pol-Rodriquez M., Lee S., Silvers D.N., and Celebi J.T. Influence of age on survival in childhood Spitzoid melanomas. Cancer 109 (2007) 1579-1583
9. Busam K.J., and Pulitzer M. Sentinel lymph node biopsy for patients with diagnostically controversial Spitzoid melanocytic tumors?. Adv Anat Pathol 15 (2008) 253-262
10. Lee C.C., Faries M.B., Wanek L.A., and Morton D.L. Improved survival after lymphadenectomy for nodal metastases from an unknown primary melanoma. J Clin Oncol 26 (2008) 535-541
11. Morton D.L., Thompson J.F., Cochran A.J., Mozzillo M., Elashoff R., Essner R., et al. Sentinel node biopsy or nodal observation in melanoma. N Engl J Med 355 (2006) 1307-1317
12. McGovern V.J., Shaw H.M., and Milton G.W. Prognosis in patients with thin melanoma: influence of regression. Histopathology 7 (1983) 673-680
13. Wanebo H.J., Cooper P.H., and Hagar R.W. Thin (less than or equal to 1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression. Ann Surg 201 (1985) 499-504
14. Clark W.H., Elder D., Guerry DuPont I.V., Braitman L.E., Rock B.J., Schultz D., et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst 81 (1989) 1893-1904
15. Paladuga R.R., and Yonemoto R.H. Biological behavior of thin malignant melanomas with regressive changes. Arch Surg 118 (1983) 41-44
16. Ronan S.G., Eng A.M., Briele H.A., Shioura N.N., and Das Gupta T.K. Thin malignant melanomas with regression and metastases. Arch Dermatol 123 (1987) 1326-1330
17. Byers H.R., and Bhawan J. Pathologic parameters in the diagnosis and prognosis of primary cutaneous melanoma. Hematol Oncol Clin North Am 12 (1988) 717-735
18. Balch C.M., and Lange J.R. Lymphatic mapping and sentinel node lymphadenectomy for cancer: an overview. Ann Surg Oncol 8 Suppl (2001) 1S-4S
19. Weiss M., Loprinzi C.L., Creagan E.T., Dalton R.J., Novotny P., and O'Fallon J.R. Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas. JAMA 274 (1995) 1703-1705
20. Poo-Hwu W.-J., Ariyan S., Lamb L., Papac R., Zelterman D., Hu G.L., et al. Follow-up recommendations for patients with American Joint Committee on Cancer stages I-III malignant melanoma. Cancer 86 (1999) 2252-2258